NK-2 [R4P,T13P]

General Information


DRACP ID  DRACP03942

Peptide Name   NK-2 [R4P,T13P]

Sequence  KILPGVCKKIMRPFLRRISKDILTGKK

Sequence Length  27

UniProt ID  Q29075 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C143H256N42O32S2

Absent amino acids  AEHNQWY

Common amino acids  K

Mass  360393

Pl  11.82

Basic residues  9

Acidic residues  1

Hydrophobic residues  9

Net charge  8

Boman Index  -4578

Hydrophobicity  -18.89

Aliphatic Index  111.85

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 29043494

Title  Influence of Proline Substitution on the Bioactivity of Mammalian-Derived Antimicrobial Peptide NK-2

Doi Not available

Year  2018

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  14420

DRACP is developed by Dr.Zheng's team.